🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this trial is to examine the effect of immediate versus la...
Status
Recruiting
Location
Sahlgrenska University Hospital
Start Date
2025-01-06
Trial ID
NCT06562582
Treatments Being Tested
The purpose of the study is to assess the effects of rifampin on the pharma...
Status
Terminated
Location
Ppd Development
Start Date
2010-03
Trial ID
NCT01068756
Treatments Being Tested
Long-term allograft function in kidney transplant recipients (KTRs) remain ...
Status
Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2024-02-01
Trial ID
NCT06140537
Treatments Being Tested
Bioequivalence study for the fixed-dose combination of Gemigliptin/Dapaglif...
Status
Completed
Location
Jeonbuk National University Hospital
Start Date
2026-01-09
Trial ID
NCT07399470
There are approximately 400,000 people in the UK who are living with type 1...
Status
Terminated
Location
Clinical Research Unit, OCDEM, Churchill Hospital
Start Date
2018-06-02
Trial ID
NCT03537131
Treatments Being Tested
This is a randomised, placebo-controlled, double-blind, parallel-group, int...
Status
Completed
Location
Research Site
Start Date
2018-02-28
Trial ID
NCT03387683
Treatments Being Tested
This is an international, multicentre, parallel-group, event-driven, random...
Status
Completed
Location
Research Site
Start Date
2018-08-27
Trial ID
NCT03619213
Treatments Being Tested
This study aims at exploring the use of Dapagliflozin and Empagliflozin in ...
Status
Unknown
Location
Centre Hospitalier Universitaire Vaudois (CHUV)
Start Date
2024-08
Trial ID
NCT06012266
Treatments Being Tested
The study will have 2 independent parts: Part 1 of the study is intended t...
Status
Completed
Location
Research Site
Start Date
2021-07-29
Trial ID
NCT04991571
Dapagliflozin is a highly selective, reversible and potent inhibitor of the...
Status
Completed
Location
Medical University Innsbruck, Department of Internal Medicine I
Start Date
2014-08
Trial ID
NCT02211742
Treatments Being Tested